Travelers Companies, Inc.
Overview
A research memo on Travelers: what it sells and where one premium dollar goes, a USD 100 premium money ladder, peers and share of the US P&C market, 2030 bust/base/boom core income scenarios, a 31 Oct 2026 valuation with two-method per-share values, a revenue-quality test that separates underlying underwriting from catastrophes and reserve releases, and a leadership, letters and insider review.
| Information | Status | As of |
|---|---|---|
| Detailed research report | Yes | 2026-10-31 |
| Rule-based screens | On 1 shortlist: Top Momentum | 2026-10-31 |
| Valuation | Model 340.76 (-14% vs price); Above fair value · -16% to USD 334 | 2026-10-31, 2026-10-30 |
| Chart-pattern read | Up +5% to target, Double bottom (confirmed) | 2026-10-30 |
| Paper portfolio | Held since 2026-10-15 | 2026-10-30 |
Research
Peak underwriting, softening prices, and a share price above both anchors
Quality franchise, fully priced. Core ROE is 22% year to date, but underlying underwriting income is flat; the growth came from light catastrophes, reserve releases and investment income, while Business Insurance renewal pricing slowed four quarters running to 4.1% and Personal Auto premiums fell 8%. At USD 396.22 (2.30x adjusted book, 12.7x 2027 consensus EPS) the price is 7.1% above the average of the S&P Global consensus target (376.54) and our base case (363.6); Morningstar pending. Scenario values today USD 204 bust, 364 base, 534 boom. Executives sold about USD 69M in October with no insider buys in 2026. Next hard test: Q4 2026 report, expected late January 2027.
Reviewed 31 Oct 2026 · IBKR ratings pending
Scores
On the current shortlists: Top Momentum (#7).
| Method | Score | Inputs as of | Flags |
|---|---|---|---|
| Graham Defensive | n/a | ||
| Magic Formula | n/a | ||
| Momentum | 86 | 2026-10-30 | |
| Insider | 0 | 2026-10-30 | |
| Buffett Quality | n/a | ||
| Lynch GARP | n/a | ||
| Graham Enterprising | n/a | ||
| Piotroski F-Score | n/a |
Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.
Valuation
340.76 -14% vs price
Range 295.49 to 386.03, 2 of 3 methods agree. A labelled model estimate, not a price target. Method.
Above fair value · -16% to USD 334
Average of the dated sources shown in the report, with the price chart. Open the fair-value section.
Charts
Up +5% · Double bottom, confirmed
Book base rate 95% that such a breakout keeps going; 66% reached the full target. Historical frequencies, not a probability for this stock.
Portfolio activity Paper
Held: 13.55 shares at an average cost of 381.46, 9.3% of the account, opened 2026-10-15; unrealized +3.87%.
| Date | Action | Shares | Price |
|---|---|---|---|
| 2026-10-15 | BUY | 13.55 | 381.46 |